New trends in treatment of breast cancer
More than one hundred young specialists were invited by the Shanghai Roche Pharmaceutical Co. Ltd. to participate in a forum focusing on the treatment of breast cancer recently. The specialists attended the meeting carried out an ardent discussion on the present incidence of breast cancer, the new agents for the management as well as the hot spots of recent research.
Professor Shen Kunwei of Oncology Hospital affiliated to Shanghai Fudan University recommended a new agent for adjuvant treatment of breast cancera humanized monoclonal antibody called Herceptin, which acts through a specific anti- HER-2 receptor and inhibits the proliferation of tumor cells and effectively treats solid tumors. Professor Xu Binghe of Oncology Hospital, Chinese Academy of Medical Science considered that the drug resistance to anthracene and paclitaxel was one of the frequently encountered problems during the treatment of advanced cases of breast cancer. At this moment, the routine regime of chemotherapy combined with oral administration of capecitabine is able to improve the therapeutic effect. Professor Jiang Zefei of army 307th hospital proposed the individualized principle of breast cancer treatment, that the physician in charge should select a management regimen targetting directly at the patient's condition., http://www.100md.com
Professor Shen Kunwei of Oncology Hospital affiliated to Shanghai Fudan University recommended a new agent for adjuvant treatment of breast cancera humanized monoclonal antibody called Herceptin, which acts through a specific anti- HER-2 receptor and inhibits the proliferation of tumor cells and effectively treats solid tumors. Professor Xu Binghe of Oncology Hospital, Chinese Academy of Medical Science considered that the drug resistance to anthracene and paclitaxel was one of the frequently encountered problems during the treatment of advanced cases of breast cancer. At this moment, the routine regime of chemotherapy combined with oral administration of capecitabine is able to improve the therapeutic effect. Professor Jiang Zefei of army 307th hospital proposed the individualized principle of breast cancer treatment, that the physician in charge should select a management regimen targetting directly at the patient's condition., http://www.100md.com